Developing, commercializing, protecting and distributing products are ever-present priorities for life science companies. As they look to take advantage of global scientific breakthroughs, they demand a partner who can help them maximize business opportunities around the world. International law firm ZAG-S&W is that partner.
Life Sciences companies benefit from our real-world understanding of the issues facing medical device, pharmaceutical, biotech, medtech companies, and many more. Within these specialist fields, we advise domestic and international corporations, both public and private, as well as healthcare institutions, universities, private equity investors and financial institutions on all legal aspects relating to their operation, expansion and long-term strategic objectives.
Our immersion in this sector is illustrated by our representation of more than 20 life science companies that are traded on Nasdaq, guiding them through every step of their journey, from the early seed financing to raising money in the capital markets.
From the outset we create innovative strategic agreements, engagements for conducting clinical trials, collaborations with academic institutions, distribution and licensing agreements and intellectual property. We also provide counsel in relation to financing – whether it comes from private equity investment, the banks or capital markets – and support clients in relation to their M&A transactions, going public, tax, real estate, labor, commercial or IP litigation, and much more.
Recent highlights include the creation of inaugural funds investing in the life sciences sector, drafting and negotiating international joint research and development agreements in various medical fields, and negotiating exclusive worldwide licenses.
In this ever-changing global industry, our clients benefit from working with ZAG-S&W, which operates seamlessly across departments and borders, helping life science companies and their investors to take advantage of opportunities and navigate challenges.